Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Clearpoint Neuro Inc. (CLPT)

4.16   0.09 (2.21%) 06-01 12:47
Open: 4.07 Pre. Close: 4.07
High: 4.53 Low: 4.07
Volume: 35,477 Market Cap: 65M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.226 - 4.248 4.248 - 4.265
Low: 3.952 - 3.974 3.974 - 3.992
Close: 4.038 - 4.072 4.072 - 4.101

Technical analysis

as of: 2020-06-01 12:26:28 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.34     One year: 6.23
Support: Support1: 3.54    Support2: 2.90
Resistance: Resistance1: 4.57    Resistance2: 5.34
Pivot: 3.64
Moving Average: MA(5): 4.10     MA(20): 3.62
MA(100): 4.16     MA(250):
MACD: MACD(12,26): 0.12     Signal(9): 0.03
Stochastic oscillator: %K(14,3): 74.69     %D(3): 70.51
RSI: RSI(14): 59.40
52-week: High: 6.33  Low: 2.86  Change(%): 19.4
Average Vol(K): 3-Month: 3917  10-Days: 4787

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
CLPT has closed below upper band by 18.5%. Bollinger Bands are 22.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 12 May 2020
ClearPoint Neuro Reports First Quarter 2020 Results Nasdaq:CLPT - GlobeNewswire

Thu, 07 May 2020
Corrected: ClearPoint Neuro to Announce First Quarter 2020 Results on May 12 - GlobeNewswire

Wed, 13 May 2020
What is Forecast Price for Clearpoint Neuro Inc (CLPT) Stock? - InvestorsObserver

Tue, 11 Feb 2020
MRI Interventions, Inc. Changes Corporate Name to ClearPoint Neuro, Inc. - GlobeNewswire

Mon, 13 Jan 2020
MRI Interventions, Inc. To Change Corporate Name to ClearPoint Neuro, Inc. - GlobeNewswire

Wed, 12 Feb 2020
ClearPoint Neuro Reports 53% Increase in 2019 Revenue Nasdaq:CLPT - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector: 
Industry: 
Shares Out. (M) 16
Shares Float (M) 10
% Held by Insiders 45.44
% Held by Institutions 7.10
Shares Short (K) 6
Shares Short P. Month (K) 7

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin -53.74
Operating Margin -40.72
Return on Assets (ttm) -19.3
Return on Equity (ttm) -398.1
Qtrly Rev. Growth 26.0
Gross Profit (p.s.) 0.476
Sales Per Share 0.765
EBITDA (p.s.) -0.300
Qtrly Earnings Growth
Operating Cash Flow (M) -5
Levered Free Cash Flow (M) -2

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales 5.47
Price to Cash Flow -14.19

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.